APC-Labeled Monoclonal Anti-Human CD73 Antibody, Mouse IgG1 (5A10) (0.03% Proclin)

Cat. No. / Size
Price
Availability
Qty
FABm024-02-50tests
$210.00
FABm024-02-100tests (50tests X 2)
$220.00
FABm024-02
Sub-Total :
$ 0
Customize Product Request Quote
Contact Us
Contact Us
Sub-Total:
$ 0
  • Product Details
  • Performance Data
  • Reviews & Citations
  • Important Statement
  • Resources
Source

Monoclonal Anti-Human CD73 Antibody, Mouse IgG1 (5A10) is a mouse monoclonal antibody recombinantly expressed from Hybridoma.

Antibody Type

Hybridoma Monoclonal

Clone

5A10

Isotype

Mouse Fc, Kappa

Host Species

Mouse

Reactivity

Human

Immunogen

Purified Human CD73 Protein

Conjugate

APC

Excitation Wavelength: 640 nm

Emission Wavelength: 661 nm

Specificity

This product is a specific antibody specifically reacts with CD73 protein.

Application

Flow Cytometry (Evaluation of the expression of CD73 on Human cells).

Recommended Dilution

1:20

Form

Liquid

Formulation

Supplied as 0.2 μm-filtered solution in PBS (pH 7.4) containing 0.03% ProClin 300 and 0.2% BSA, with trehalose as protectant.

Please contact us for customized product forms or formulations.

Shipping

Liquid product is shipped at blue ice.

Storage

Please protect from light and avoid repeated freeze-thaw cycles.

This product is stable after storage at:
  • Store at 2-8 °C for 12 months.
Notices

Product Specific Notices: For research use only.

Background

5'-nucleotidase (5'-NT), also known as ecto-5'-nucleotidase or CD73 (cluster of differentiation 73), is an enzyme that is encoded by the NT5E gene. CD73 commonly serves to convert AMP to adenosine. Ecto-5-prime-nucleotidase (5-prime-ribonucleotide phosphohydrolase) catalyzes the conversion at neutral pH of purine 5-prime mononucleotides to nucleosides, the preferred substrate being AMP. Other forms of 5-prime nucleotidase exist in the cytoplasm and lysosomes and can be distinguished from ecto-NT5 by their substrate affinities, requirement for divalent magnesium ion, activation by ATP, and inhibition by inorganic phosphate. Rare allelic variants are associated with a syndrome of adult-onset calcification of joints and arteries (CALJA) affecting the iliac, femoral, and tibial arteries reducing circulation in the legs and the joints of the hands and feet causing pain.